Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 30Anemia, Refractory, with Excess of Blasts 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Myelodysplastic Syndromes 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19Multiple Myeloma 16Hodgkin Disease 16Anemia, Aplastic 16Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 15Myeloproliferative Disorders 12Lymphoma 11Primary Myelofibrosis 10Hematologic Neoplasms 10Leukemia 9Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 5Polycythemia Vera 4Immunologic Deficiency Syndromes 4Hemoglobinopathies 4Fanconi Anemia 4Burkitt Lymphoma 4Blast Crisis 4Anemia, Sickle Cell 4Anemia, Refractory 4Anemia 4Thalassemia 3Recurrence 3

Interventions

fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × fludarabine × Classical hematology × Clear all
NCT04083170 2025-01-01

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Fred Hutchinson Cancer Center

Phase 2 Terminated
1 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, HIV Infections, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡